pubmed-article:16009950 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16009950 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:16009950 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
pubmed-article:16009950 | lifeskim:mentions | umls-concept:C0007137 | lld:lifeskim |
pubmed-article:16009950 | lifeskim:mentions | umls-concept:C0460004 | lld:lifeskim |
pubmed-article:16009950 | lifeskim:mentions | umls-concept:C0003250 | lld:lifeskim |
pubmed-article:16009950 | lifeskim:mentions | umls-concept:C0206454 | lld:lifeskim |
pubmed-article:16009950 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
pubmed-article:16009950 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
pubmed-article:16009950 | lifeskim:mentions | umls-concept:C0034897 | lld:lifeskim |
pubmed-article:16009950 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
pubmed-article:16009950 | lifeskim:mentions | umls-concept:C0995188 | lld:lifeskim |
pubmed-article:16009950 | lifeskim:mentions | umls-concept:C1096776 | lld:lifeskim |
pubmed-article:16009950 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:16009950 | lifeskim:mentions | umls-concept:C1514162 | lld:lifeskim |
pubmed-article:16009950 | pubmed:issue | 24 | lld:pubmed |
pubmed-article:16009950 | pubmed:dateCreated | 2005-8-19 | lld:pubmed |
pubmed-article:16009950 | pubmed:abstractText | To evaluate the efficacy and safety of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). | lld:pubmed |
pubmed-article:16009950 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16009950 | pubmed:language | eng | lld:pubmed |
pubmed-article:16009950 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16009950 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16009950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16009950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16009950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16009950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16009950 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16009950 | pubmed:month | Aug | lld:pubmed |
pubmed-article:16009950 | pubmed:issn | 0732-183X | lld:pubmed |
pubmed-article:16009950 | pubmed:author | pubmed-author:BaselgaJoséJ | lld:pubmed |
pubmed-article:16009950 | pubmed:author | pubmed-author:BourhisJeanJ | lld:pubmed |
pubmed-article:16009950 | pubmed:author | pubmed-author:Cortés-FunesH... | lld:pubmed |
pubmed-article:16009950 | pubmed:author | pubmed-author:TrigoJosé MJM | lld:pubmed |
pubmed-article:16009950 | pubmed:author | pubmed-author:TortochauxJac... | lld:pubmed |
pubmed-article:16009950 | pubmed:author | pubmed-author:GascónPereP | lld:pubmed |
pubmed-article:16009950 | pubmed:author | pubmed-author:EckardtAndréA | lld:pubmed |
pubmed-article:16009950 | pubmed:author | pubmed-author:HittRicardoR | lld:pubmed |
pubmed-article:16009950 | pubmed:author | pubmed-author:HarstrickAndr... | lld:pubmed |
pubmed-article:16009950 | pubmed:author | pubmed-author:AmellalNadiaN | lld:pubmed |
pubmed-article:16009950 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16009950 | pubmed:day | 20 | lld:pubmed |
pubmed-article:16009950 | pubmed:volume | 23 | lld:pubmed |
pubmed-article:16009950 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16009950 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16009950 | pubmed:pagination | 5568-77 | lld:pubmed |
pubmed-article:16009950 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:meshHeading | pubmed-meshheading:16009950... | lld:pubmed |
pubmed-article:16009950 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:16009950 | pubmed:articleTitle | Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck. | lld:pubmed |
pubmed-article:16009950 | pubmed:affiliation | Vall d'Hebron University Hospital, Oncology Service, P Vall d'Hebron 119-129, Barcelona 08035, Spain. jbaselga@vhebron.net | lld:pubmed |
pubmed-article:16009950 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16009950 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:16009950 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:16009950 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:16009950 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:16009950 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16009950 | lld:pubmed |